{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:30:47Z","timestamp":1791653447994,"version":"4.3.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>The risk of heart failure progression or mortality in patients with peri-partum cardiomyopathy (PPCM) during subsequent pregnancies (SSPs) is a significant concern for patients, their families, and healthcare providers. However, there is limited contemporary, prospective data on SSP outcomes in PPCM patients from diverse ethnic and sociodemographic groups. This study aimed to assess maternal and neonatal outcomes in PPCM patients undergoing SSPs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a sub-study on PPCM and SSPs of the global European Society of Cardiology PPCM Registry that recruited patients from 2012 to 2023. Maternal and neonatal outcomes were reported.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From 332 patients with PPCM, there were 98 SSPs among 73 women. Of these, 25 (26%) SSPs ended prematurely due to therapeutic termination (20\/25), miscarriage (4\/25), and stillbirth (1\/25). The median follow-up from the end of the SSP was 198 days (inter-quartile range 160\u2013240). Left ventricular ejection fraction (LVEF) was persistently reduced to &amp;lt;50% prior to the SSP in 26% of patients, with only 6% having an LVEF &amp;lt;40%. Patient characteristics were similar, irrespective of SSP baseline LVEF. Clinical worsening [composite of all-cause death, cardiovascular rehospitalization, or decline in LVEF \u226510% (percentage points) and to &amp;lt;50%] occurred in 20% SSPs, with 2% all-cause maternal mortality. Signs\/symptoms of heart failure and worsening of New York Heart Association class occurred in 26% and 22% of SSPs, respectively. At follow-up, the mean LVEF was 50% (\u00b112%), and in 69% of SSPs, the LVEF was \u226550%. African women had similar outcome as the other ethnic groups. Pre-term delivery occurred in 24% of SSPs, 20% of babies were of low birth weight, and there was 3% all-cause neonatal mortality. Compared with women with SSP baseline LVEF &amp;lt;50%, fewer women with LVEF \u226550% were on heart failure pharmacotherapies prior to the SSP, and in this group of women, there was a significant decline in LVEF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Maternal morbidity and mortality rates were lower than anticipated. Baseline LVEF &amp;lt;50% was not associated with an increased frequency of adverse maternal outcomes, and no further decline in LVEF was observed in this group. In contrast, women with SSPs and a baseline LVEF \u226550% experienced a decline in LVEF, potentially attributable to reduced use of heart failure pharmacotherapy during pregnancy and the post-partum period. Therapeutic termination was performed in approximately a fifth of cases. The findings suggest that reclassification of a SSP with persisting mild left ventricular impairment from modified World Health Organization (mWHO) Class IV (contraindicated) to mWHO III may be considered, while remaining under the care of an experienced medical team and with appropriate pharmacological management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaf006","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T20:19:02Z","timestamp":1735849142000},"page":"1031-1040","source":"Crossref","is-referenced-by-count":27,"title":["Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-0911","authenticated-orcid":false,"given":"Karen","family":"Sliwa","sequence":"first","affiliation":[{"name":"Cape Heart Institute, Department of Cardiology and Medicine, Faculty of Health Sciences, University of Cape Town , 4th floor Chris Barnard Building, Observatory, Cape Town 7925 ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Jackson","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charle","family":"Viljoen","sequence":"additional","affiliation":[{"name":"Cape Heart Institute, Department of Cardiology and Medicine, Faculty of Health Sciences, University of Cape Town , 4th floor Chris Barnard Building, Observatory, Cape Town 7925 ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0925-494X","authenticated-orcid":false,"given":"Albertino","family":"Damasceno","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Eduardo Mondlane University , Maputo ,","place":["Mozambique"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mbanze","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Eduardo Mondlane University , Maputo ,","place":["Mozambique"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Al","family":"Farhan","sequence":"additional","affiliation":[{"name":"Iraqi Board for Medical Specializations, Scientific Council of Cardiology, College of Medicine, University of Baghdad, Baghdad Heart Center , Baghdad ,","place":["Iraq"]},{"name":"Baghdad Teaching Hospital, Department of Medicine and Cardiology, Medical City , Baghdad ,","place":["Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa Fadhil","family":"Yaseen","sequence":"additional","affiliation":[{"name":"Iraqi Board for Medical Specializations, Scientific Council of Cardiology, College of Medicine, University of Baghdad, Baghdad Heart Center , Baghdad ,","place":["Iraq"]},{"name":"Baghdad Teaching Hospital, Department of Medicine and Cardiology, Medical City , Baghdad ,","place":["Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amam","family":"Mbakwem","sequence":"additional","affiliation":[{"name":"Department of Cardiology, College of Medicine and Lagos University Teaching Hospital , Lagos ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triwedya Indra","family":"Dewi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, Faculty of Medicine, Bandung Hasan Sadikin General Hospital , Bandung ,","place":["Indonesia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Dzielinska","sequence":"additional","affiliation":[{"name":"Cardinal Wyszynski National Institute of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Abdullaev","sequence":"additional","affiliation":[{"name":"Specialized Scientific Medical Centre , Department of Medicine and Cardiology, Tashkent ,","place":["Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5821-1113","authenticated-orcid":false,"given":"Sorel","family":"Goland","sequence":"additional","affiliation":[{"name":"Heart Institute, Department of Cardiology, Kaplan Medical Centre, Rehovot, Hebrew University , Jerusalem ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Hilfiker-Kleiner","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Philipps University Marburg , Marburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hahnle","sequence":"additional","affiliation":[{"name":"Cape Heart Institute, Department of Cardiology and Medicine, Faculty of Health Sciences, University of Cape Town , 4th floor Chris Barnard Building, Observatory, Cape Town 7925 ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-0673","authenticated-orcid":false,"given":"Carmen","family":"Basic","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Frogoudaki","sequence":"additional","affiliation":[{"name":"Atticon University Hospital , Department of Cardiology, Chaidari ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Seferovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[{"name":"University Medical Centre Groningen , Department of Cardiology, Groningen ,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-9496","authenticated-orcid":false,"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School , Hannover ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"2025042311171145400_ehaf006-B1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2025042311171145400_ehaf006-B2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025042311171145400_ehaf006-B3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy)","volume":"66","author":"McNamara","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025042311171145400_ehaf006-B4","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ejhf.2603","article-title":"A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta-analysis","volume":"24","author":"Hoevelmann","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025042311171145400_ehaf006-B5","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/eurheartj\/ehab458","article-title":"Peripartum cardiomyopathy: from genetics to management","volume":"42","author":"Sliwa","year":"2021","journal-title":"Eur Heart J"},{"key":"2025042311171145400_ehaf006-B6","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"2025042311171145400_ehaf006-B7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ejhf.68","article-title":"EURObservational research programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM","volume":"16","author":"Sliwa","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2025042311171145400_ehaf006-B8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/ejhf.780","article-title":"Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM","volume":"19","author":"Sliwa","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2025042311171145400_ehaf006-B9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ejhf.1178","article-title":"Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy","volume":"20","author":"Sliwa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025042311171145400_ehaf006-B10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ejhf.808","article-title":"Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy","volume":"19","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2025042311171145400_ehaf006-B11","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1093\/eurheartj\/ehaa455","article-title":"Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry","volume":"41","author":"Sliwa","year":"2020","journal-title":"Eur Heart J"},{"key":"2025042311171145400_ehaf006-B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jacc.2023.04.043","article-title":"Long-term outcomes of women with peripartum cardiomyopathy having subsequent pregnancies","volume":"82","author":"Pachariyanon","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025042311171145400_ehaf006-B13","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJM200105243442101","article-title":"Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy","volume":"344","author":"Elkayam","year":"2001","journal-title":"N Engl J Med"},{"key":"2025042311171145400_ehaf006-B14","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1002\/ehf2.14141","article-title":"Contemporary outcome of subsequent pregnancies in patients with previous peripartum cardiomyopathy","volume":"9","author":"Goland","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2025042311171145400_ehaf006-B15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12872-018-0856-7","article-title":"Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy","volume":"18","author":"Yameogo","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2025042311171145400_ehaf006-B16","doi-asserted-by":"publisher","first-page":"131596","DOI":"10.1016\/j.ijcard.2023.131596","article-title":"Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: a study of the ESC EORP PPCM registry","volume":"398","author":"Sliwa","year":"2024","journal-title":"Int J Cardiol"},{"key":"2025042311171145400_ehaf006-B17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/ejhf.2133","article-title":"Risk stratification and management of women with cardiomyopathy\/heart failure planning pregnancy or presenting during\/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy","volume":"23","author":"Sliwa","year":"2021","journal-title":"Eur J Heart Fail"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/11\/1031\/61857726\/ehaf006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/11\/1031\/61857726\/ehaf006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:17:21Z","timestamp":1745421441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/11\/1031\/8010207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf006","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3,14]]},"published":{"date-parts":[[2025,2,12]]}}}